tiprankstipranks
Avenue Therapeutics (ATXI)
:ATXI
US Market

Avenue Therapeutics (ATXI) Income Statement

Compare
321 Followers

Avenue Therapeutics Income Statement

Last quarter (Q3 2024), Avenue Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Avenue Therapeutics's net income was $-3.08M. See Avenue Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 14.54M$ 8.04M$ 3.74M$ 5.21M$ 26.27M
Depreciation and Amortization
$ 14.54M$ 8.04M$ 3.74M$ 5.21M$ 26.27M
EBITDA
$ 4.05M$ 0.00$ 0.00$ -5.21M$ 0.00
Operating Income
$ -14.54M$ -8.04M$ -3.74M$ -5.21M$ -26.27M
Other Income/Expenses
$ 4.05M$ 4.44M$ 7.00K$ 62.00K$ 357.00K
Pretax Income
$ -10.49M$ -3.60M$ -3.73M$ -5.15M$ -25.91M
Net Income
$ -10.38M$ 2.05M$ -3.72M$ -5.09M$ -25.55M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -73.60$ 0.94$ -3.29$ -4.62$ -24.38
Diluted EPS
$ -73.48$ 0.94$ -3.29$ -4.62$ -24.38
Weighted Average Shares Outstanding
141.00K 2.19M 1.13M 1.10M 1.05M
Weighted Average Shares Outstanding (Diluted)
141.22K 2.19M 1.13M 1.10M 1.05M
Currency in USD

Avenue Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis